Live Breaking News & Updates on Retinopathy Pipeline Insight

Stay updated with breaking news from Retinopathy pipeline insight. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AI in healthcare: A double-edged sword? Study reveals impact on diagnostic accuracy

Study investigates the impact of AI on clinicians' diagnostic accuracy, revealing that AI explanations don't significantly mitigate the harmful effects of biased AI models, emphasizing the need for careful validation of AI tools in clinical settings. ....

Yuria Shutterstock , Hospitalized Patients , Randomized Clinical Vignette Survey , Image Credit , Artificial Intelligence , Diabetic Retinopathy , Skin Cancer ,

Understanding Familial Exudative Vitreoretinopathy

Familial exudative vitreoretinopathy (FEVR) is a rare genetic disorder that affects the development of the blood vessels in the retina. ....

Novel Study , Molecular Genetics , Metabolism Reports , Endoplasmic Reticulum , Familial Exudative Vitreoretinopathy , Eye Disease , Vision Loss ,

Study identifies key factor in lung and eye damage in preemies

Advancements in the care of premature babies are leading to improved survival rates. However, the incidence of neonatal diseases with life-long consequences such as bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) is increasing. ....

United States , Margaretl Hibbs , Department Of Immunology , Leukocyte Signalling Laboratory , Central Clinical School , Monash University , American Journal , Bronchopulmonary Dysplasia , Ung Disease , Retinopathy Of Prematurity ,

Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema

Lead ophthalmology candidate EXN407 has potential to be the first topical treatment for diabetic retinopathy/diabetic macular oedema. ....

Danielle Ellis , Exonate Ltd , Janssen Pharmaceuticals Inc , Janssen Pharmaceuticals , Diabetic Retinopathy ,

Falk Trust awards $1.35 million to Case Western Reserve researchers for cancer and diabetic retinopathy treatments

A combined $1.35 million from the Dr. Ralph and Marian Falk Medical Research Trust was awarded to two researchers from the Case Western Reserve University School of Medicine to advance their work on finding more effective treatments-;and better options-;for two debilitating diseases. ....

United States , Carlos Subauste , Marian Falk , Oncology Program , Division Of Hematology Oncology , Falk Catalyst Awards Program , Foundation At Health Resources In Action , School Of Medicine , Catalyst Research Award Program , Case Western Reserve University , Transformational Research Award , Department Of Medicine , Case Western Reserve University School Of Medicine , Marian Falk Medical Research , Western Reserve , Marian Falk Medical Research Trust , Case Western Reserve University School , Falk Trust , Reshmi Parameswaran , Immune Oncology Program , Case Comprehensive Cancer , Case Western Reserve , Vascular Endothelial Growth Factor , Medical Foundation , Health Resources , Medical Research ,